Harnessing the Potential of Astrocytes to Treat Brain Injuries and Diseases

Astrocyte Pharmaceuticals is developing innovative neuroprotection therapies for Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorders

Learn More

Brain Injuries

Brain injuries are a distressingly common medical condition and one of the leading causes of death and disability worldwide. The brain is particularly vulnerable to injury as neurons have a limited capacity to repair.

LEARN MORE

The Science

The importance of astrocytes and other glia cells are only now being fully investigated and appreciated for their multifunctional role, including their critical roles in the maintenance and repair of the brain after injury.

LEARN MORE

Portfolio

Astrocyte Pharmaceuticals is currently investigating several programs for the potential treatment of acute ischemic stroke, TBI, concussion, and other injuries to the brain.

Learn More

News

Senator Chris Murphy Highlights Groton’s Astrocyte Pharmaceuticals As “Innovator Of The Month”

September 8, 2024

Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004

March 12, 2024

Alzheimer’s Drug Discovery Foundation Joins Astrocyte Pharmaceuticals’ $6M+ Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004

August 18, 2023

Astrocyte Pharmaceuticals Announces Theodore Liston, Ph.D., Vice President of Research, as Recipient of the 2022 Innovation and Progress Award from the Journal Stroke

April 10, 2023

See all News & Media Highlights

Overview
Brain Injuries
Science
Portfolio

News
Team
Investors
Contact

By using this website, you agree to our use of cookies. We use cookies to improve your browsing experience. To learn more about the cookies we use, see our Privacy Policy.